Dare Bioscience Inc (DARE)
0.4889
+0.05
(+12.44%)
USD |
NASDAQ |
May 17, 16:00
0.4889
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Net Income (Quarterly): -5.058M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.058M |
| September 30, 2023 | -8.299M |
| June 30, 2023 | -8.762M |
| March 31, 2023 | -8.042M |
| December 31, 2022 | -15.94M |
| September 30, 2022 | -7.020M |
| June 30, 2022 | 0.414M |
| March 31, 2022 | -8.399M |
| December 31, 2021 | -9.542M |
| September 30, 2021 | -12.67M |
| June 30, 2021 | -9.163M |
| March 31, 2021 | -7.324M |
| December 31, 2020 | -8.442M |
| September 30, 2020 | -7.583M |
| June 30, 2020 | -7.124M |
| March 31, 2020 | -4.252M |
| December 31, 2019 | -3.866M |
| September 30, 2019 | -3.393M |
| June 30, 2019 | -3.952M |
| March 31, 2019 | -3.052M |
| December 31, 2018 | -2.917M |
| September 30, 2018 | -2.574M |
| Date | Value |
|---|---|
| June 30, 2018 | -3.582M |
| March 31, 2018 | -7.666M |
| December 31, 2017 | -9.131M |
| September 30, 2017 | -1.630M |
| June 30, 2017 | -0.4982M |
| March 31, 2017 | -0.2439M |
| December 31, 2016 | -0.2005M |
| September 30, 2016 | -0.0161M |
| June 30, 2016 | -10.86M |
| March 31, 2016 | -13.54M |
| December 31, 2015 | -10.71M |
| September 30, 2015 | -10.55M |
| June 30, 2015 | -9.907M |
| March 31, 2015 | -8.428M |
| December 31, 2014 | -7.467M |
| September 30, 2014 | -5.558M |
| June 30, 2014 | -7.403M |
| March 31, 2014 | -2.914M |
| December 31, 2013 | -3.48M |
| September 30, 2013 | -3.198M |
| June 30, 2013 | -4.893M |
| March 31, 2013 | -5.572M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-15.94M
Minimum
Dec 2022
0.414M
Maximum
Jun 2022
-7.285M
Average
-7.583M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
| Altimmune Inc | -24.39M |
| Verastem Inc | -33.86M |
| Oragenics Inc | -12.75M |
| Actinium Pharmaceuticals Inc | -8.67M |
| Orgenesis Inc | -6.623M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.808M |
| Total Expenses (Quarterly) | 6.979M |
| EPS Diluted (Quarterly) | -0.06 |
| Enterprise Value | 33.26M |
| Profit Margin (Quarterly) | -279.8% |
| Earnings Yield | -69.54% |
| Normalized Earnings Yield | -69.54 |